ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 241 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $1,678,000 | -46.5% | 24,191 | -40.7% | 0.01% | -45.5% |
Q4 2020 | $3,134,000 | -3.2% | 40,780 | -5.8% | 0.02% | 0.0% |
Q3 2020 | $3,236,000 | +26.7% | 43,280 | +6.7% | 0.02% | +10.0% |
Q2 2020 | $2,555,000 | +56.5% | 40,580 | +4.4% | 0.02% | +33.3% |
Q1 2020 | $1,633,000 | -0.4% | 38,880 | +7.8% | 0.02% | +36.4% |
Q4 2019 | $1,639,000 | -7.7% | 36,080 | -7.0% | 0.01% | 0.0% |
Q3 2019 | $1,775,000 | -25.2% | 38,780 | -4.2% | 0.01% | -31.2% |
Q2 2019 | $2,373,000 | +207.8% | 40,480 | +135.5% | 0.02% | +166.7% |
Q1 2019 | $771,000 | +16.5% | 17,191 | +1.2% | 0.01% | +20.0% |
Q4 2018 | $662,000 | -11.9% | 16,991 | -1.5% | 0.01% | 0.0% |
Q2 2018 | $751,000 | +12.3% | 17,242 | +1.8% | 0.01% | +25.0% |
Q1 2018 | $669,000 | – | 16,942 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 252,500 | $11,320,000 | 4.95% |
Rubric Capital Management LP | 857,103 | $38,424,000 | 3.59% |
PFM Health Sciences, LP | 3,255,230 | $145,932,000 | 3.22% |
Partner Investment Management, L.P. | 40,605 | $1,820,000 | 2.10% |
DAFNA Capital Management LLC | 93,942 | $4,211,000 | 1.82% |
Atika Capital Management LLC | 195,000 | $8,742,000 | 1.78% |
Perceptive Advisors | 1,400,171 | $62,770,000 | 1.77% |
EMORY UNIVERSITY | 47,779 | $2,142,000 | 1.51% |
Rhenman & Partners Asset Management AB | 234,558 | $10,515,000 | 1.23% |
Eversept Partners, LP | 75,721 | $3,394,572 | 0.99% |